Dr. Jeevith R. Kanukunta, MD

Dr. Kanukunta practices at Atlanta Heart Associates in Stockbridge, Georgia.

Dr. Kanukunta's NPI, 1851338727, was assigned on June 1, 2006. Dr. Kanukunta holds Georgia license 52755.

Dr. Kanukunta's primary practice is Atlanta Heart Associates, at 350 Country Club Dr, Stockbridge, GA 30281 in Henry County. The practice phone is (770) 692-4000.

Dr. Kanukunta's primary practice is Atlanta Heart Associates in Stockbridge, Georgia. Dr. Kanukunta is also affiliated with Piedmont Henry Hospital. The medical group on file is Atlanta Heart Associates. Dmand AI also links Dr. Kanukunta to 1 more hospital, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kanukunta practices, 4 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Kanukunta's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Kanukunta is licensed in Georgia.

CMS data shows 6,686 Medicare services from Dr. Kanukunta across 25 procedure codes in 2024, for 2,268 Medicare patients. Medicare paid $382,821 for them.

CMS counts 2,268 Medicare patients who saw Dr. Kanukunta in 2024. The largest group is 65 to 74, with 844 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kanukunta's median patient age at 68, with 51% women.

In 2024, Dr. Kanukunta wrote 11,204 Medicare Part D claims for 1,308 patients. 88% of them were for generic drugs. CMS names the drug for 10,909 of them, across 67 drugs with 11 or more claims each, at $1,359,278 in total drug cost. In 2023, CMS named 10,041 claims across 62 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Kanukunta for performance year 2024, reported through an alternative payment model (APM). Dr. Kanukunta accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 544 general payments to Dr. Kanukunta from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Bristol-Myers Squibb Company paid the most, $1,852.